These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 32681780)

  • 1. Survey on clinical use and non-use of recombinant human erythropoietin in European neonatal units.
    Bolte K; Maier RF
    J Perinat Med; 2020 Sep; 48(7):744-750. PubMed ID: 32681780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of short-term recombinant human erythropoietin therapy in the prevention of anemia of prematurity in very low birth weight neonates.
    Yasmeen BH; Chowdhury MA; Hoque MM; Hossain MM; Jahan R; Akhtar S
    Bangladesh Med Res Counc Bull; 2012 Dec; 38(3):119-23. PubMed ID: 23540189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g.
    Maier RF; Obladen M; Müller-Hansen I; Kattner E; Merz U; Arlettaz R; Groneck P; Hammer H; Kössel H; Verellen G; Stock GJ; Lacaze-Masmonteil T; Claris O; Wagner M; Matis J; Gilberg F;
    J Pediatr; 2002 Jul; 141(1):8-15. PubMed ID: 12091844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
    Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G
    N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of erythropoietin on erythrocyte deformability in non-transfused preterm infants.
    Klipp M; Holzwarth AU; Poeschl JM; Nelle M; Linderkamp O
    Acta Paediatr; 2007 Feb; 96(2):253-6. PubMed ID: 17429915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early treatment of premature infants with recombinant human erythropoietin.
    Messer J; Haddad J; Donato L; Astruc D; Matis J
    Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher S; Ohlsson A
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004868. PubMed ID: 16856064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early erythropoiesis-stimulating agents in preterm or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD004863. PubMed ID: 29145693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group.
    Maier RF; Obladen M; Kattner E; Natzschka J; Messer J; Regazzoni BM; Speer CP; Fellman V; Grauel EL; Groneck P; Wagner M; Moriette G; Salle BL; Verellen G; Scigalla P
    J Pediatr; 1998 May; 132(5):866-70. PubMed ID: 9602202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors related to transfusion in very low birthweight infants treated with erythropoietin.
    Maier RF; Obladen M; Messinger D; Wardrop CA
    Arch Dis Child Fetal Neonatal Ed; 1996 May; 74(3):F182-6. PubMed ID: 8777681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of Early High-Dose Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants.
    Fauchère JC; Koller BM; Tschopp A; Dame C; Ruegger C; Bucher HU;
    J Pediatr; 2015 Jul; 167(1):52-7.e1-3. PubMed ID: 25863661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia.
    Wang Y; Zhang ZG; Rhodes K; Renzi M; Zhang RL; Kapke A; Lu M; Pool C; Heavner G; Chopp M
    Br J Pharmacol; 2007 Aug; 151(8):1377-84. PubMed ID: 17603558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of short-term erythropoietin therapy in anemic premature infants.
    Reiter PD; Rosenberg AA; Valuck R; Novak K
    J Perinatol; 2005 Feb; 25(2):125-9. PubMed ID: 15526012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant erythropoietin for prevention of anemia in preterm infants.
    Obladen M; Maier RF
    J Perinat Med; 1995; 23(1-2):119-26. PubMed ID: 7658311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary erythropoietin concentrations after early short-term infusion of high-dose recombinant epo for neuroprotection in preterm neonates.
    Dame C; Langer J; Koller BM; Fauchère JC; Bucher HU
    Neonatology; 2012; 102(3):172-7. PubMed ID: 22776958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of erythropoietin in premature neonates: controversies and the future.
    Wandstrat TL; Kaplan B
    Ann Pharmacother; 1995 Feb; 29(2):166-73. PubMed ID: 7756716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher SM; Ohlsson A
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004865. PubMed ID: 16856063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with successful epoetin alfa therapy in premature infants.
    Reiter PD; Rosenberg AA; Valuck RJ
    Ann Pharmacother; 2000 Apr; 34(4):433-9. PubMed ID: 10772426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher SM; Ohlsson A
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004868. PubMed ID: 22972077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.